Marcia Cruz-Correa, MD, PhD
@mcruzcorrea
Followers
1K
Following
2K
Media
386
Statuses
711
Gastrointestinal Oncologist, Mother, Physician Scientist & CMO PanOncology Trials. Tweets are mine.
San Juan
Joined January 2014
Expedited FDA pilot project to shorten the drug approval process has included the KRAS inhibitor from Revilution Medicine (RMC-636) for Pancreas Cancer. Our team @panoncology across Puerto Rico 🇵🇷 have been actively involved in the evaluation of RMC-6236 for multiple indications
cancerletter.com
Earlier this year, FDA announced that it would be initiating a voucher program aimed at accelerating review time for applications that are deemed to be advancing U.S. “national priorities” (The...
0
0
2
Participating @ESMO Berlin during the annual congress #ESMO25 Our team presented data on ADC Met targeting agent for Stage IV Colorectal and pancreas cancer with increase ORR. Several other Bispecific antibodies are demonstrating promising results for #Pancreascancer
0
0
1
So proud of my cousin Karina Alvarado who was elected as part of the to finalist @MissUniverse It is extraordinary to see you shine and continue to pursue your dreams❤️🥳🥳🥳 Ad a nutritionist you have demonstrated the importance of dietary habits in promoting health and
0
1
3
Paradigm shifting results from the RCT for Gastric Cancer patients using IO and FLOT demonstrating benefits in DFS with the integration of IO to FLOT backbone chemo 💪🙌 MATTERHORN: Durvalumab + Chemotherapy Demonstrates Superior EFS Over Standard of Care in Resectable
dailynews.ascopubs.org
0
0
2
Mission accomplished🙌 Our @panoncology Team participated #ASCO25 presenting scientific posters and meeting with many colleagues and extraordinary scientists @BeOneMedicines @pfizer @AstellasUS @Incyte @abbvie @FDAOncology
0
0
5
In a robust article published @AACR Cancer Discoveries increasing cancer incidence for people <50 years between 2010 to 2019 was found for female breast, colorectal, kidney and uterine cancers. Multiple factors including obesity, diet and environment exposures might contribute to
0
0
4
Advanced colorectal cancer continues to be among the most common and deadliest. Tumors with microsatellite instability now received FDA approval with Opdivo/Yervoy, offers great overall survival compared to SOC as 1st line therapy. @panoncology
primerahora.com
La combinación de inmunoterapia dual nivolumab y ipilimumab provee una alternativa de tratamiento adicional para este tipo de cáncer
0
0
3
Our team had the opportunity to participate @JugandoPelotaPR to talk about #ClinicalTrials for oncology. PanOncology continues to bring to 🇵🇷 innovative options to improve outcomes 🙏 #clinicaltrials
#Health
#Innovations
#oncology
#immunotherapy
teleonce.com
Panel de expertos en oncología aborda la situación actual del cáncer en Puerto Rico y el mundo. La doctora Marcia Cruz y la doctora María Victoria, junto a ...
0
0
3
Extraordinary news for our patients with MSI-high #colorectalcancer Including patients with Lynch Sundrome and close to 10% of sporadic colon cancer. Our team collaborated in the clinical trials that evaluated the combination therapy and the patient who was ss the 1st patient in
cancernetwork.com
CancerNetwork is home to the journal Oncology & provides insights on the screening, early detection, diagnosis, treatment and prevention of cancers.
0
0
4
Congratulations to Dr. Karen Knudsen for her new stage as a CEO of Parker Institute for Cancer Immunology👏👏👏 An extraordinary scientist, leader and pioneer to join #PICI to translate research into discoveries that impact health🧡💪 #clinicaltrials
#cancerdiscoveries
cancerletter.com
Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research News AnalysisRegulatory NewsHow animal testing became a MAHA political wedge issueWhile cancer scientists...
0
0
1
A refreshing wise perspective for cancer prevention, early detection and treatment within oncology community clinical trials (@panoncology @SarahCannonDocs @ParkerInstitute @AstraZeneca) implementing and expanding USA executive policies and programs, kudos! The War on Cancer
0
0
1
Celebrating the life of Hector Luis “Tito” Cruz, my father who turned 80 years old and has the energy and health of a young man! Congratulations Papi from all your daughters, siblins, nieces/nephews, grandchildren and great grandson Atlas😍 May your life be full of health &
2
0
9
Participating @gastropr 5th Caribbean Congress on Therapeutic Congress! An extraordinary meeting with faculties from Columbia University Dr. Amrita Sethi, Jackson Memorial,@MountSinaiNYC @HopkinsMedicine @panoncology Congratulations to Dr. Kermit Richiez, President of APG, Dr.
0
0
8
Today we celebrate International Day of Women and Girls in Science. Today, tomorrow, and every day, the @AACR fosters the career development of #WomenInScience to ensure that the cancer workforce remains robust, diverse, and empowered to achieve our mission. @WomenScienceDay
0
1
10
Inmediate action @AAMC to enter in effect nationwide 👏👏👏👏 https://t.co/fbHd4XzIey
aamc.org
Judge grants restraining order after lawsuit led by the AAMC, challenging the legality of the administration’s plan to make cuts to federally funded research.
0
0
1
Very grateful to Dr. Dan Welch for the opportunity to lecture @KUCC as part of cancer biology seminar series!! Thank you for the hospitality! I even had the opportunity to visit their Proton Therapy Center with Radiation Oncology Chair Dr. Ron Chen and met brilliant dedicated
0
0
4
Our team @panoncology have been partners of BeiGene since 2018 providing access to therapies including immunotherapy with #antiPDL-1 therapy Tislelizumab for advanced gastric cancer, #Lymphoma and #colorectalcancer
This #WorldCancerDay, the theme is "United by Unique" – united against cancer, unique in our stories. At BeiGene, we believe people aren’t defined by their cancer. There is more to their story. Guided by our core value, “patients first,” we work every day to deliver innovative
0
0
1